On Wednesday, the world marks World Mosquito Day to commemorate the 1897 discovery by British doctor Sir Ronald Ross that malaria in people is transmitted to and from mosquitoes. Ross won a Nobel prize for his discovery, and, since then, mosquitoes have been enemy No 1 when it comes to defeating a disease that takes a life every single minute - most of them children in sub-Saharan Africa.But on this day, let's focus on approaching malaria in a surprising new way: a vaccine to stop humans from giving malaria to mosquitoes. If we can do this, we may finally stop malaria once and for all.
Why protect mosquitoes from humans? First, you have to understand the vicious cycle of malaria, which works like this: a mosquito bites a girl and transmits the malaria parasite, perhaps causing her to become very sick. A week later, a non-infected mosquito feeds on the same child, yet this time, it is the girl who passes the parasite to the mosquito. Soon, that mosquito - now carrying malaria parasites and buzzing around the same area - bites the girl's father, passing the parasite to him. Even if he shows no symptoms of malaria and doesn't get sick, he can still pass parasites on to another mosquito that in turn can transmit the parasite to another person, and so on.
When Rachel Carson's book, "Silent Spring", was published, filled with totally false claims about DDT, the Environmental Protection Agency looked it over and concluded she had used manipulated data.
In the sector performance report released last year by the Ministry of Health, Malaria was ranked the number one killer disease claiming about 80,000 lives.
French drugmaker Sanofi has released its first batches of a malaria treatment made from semisynthetic artemisinin using a new manufacturing process that will allow it to make tons of the ingredient and so help stabilize its volatile global market.
The World Health Organization (WHO) has declared, "A post-antibiotic era—in which common infections and minor injuries can kill—far from being an apocalyptic fantasy, is instead a very real possibility for the 21st century".
Last year, Prof Henk Bouwman of North-West University and co-authors published a paper in a respectable journal, Environmental Research, claiming that DDT spraying led to thinning of bird eggshells.
The environmental science journal Environmental Research has published an article by nine malaria experts exposing major errors in a research paper on DDT and bird eggshells.
In Southern Africa, the malaria season typically begins with the summer rains in November and ends in April. In this region, the co-ordination of malaria control efforts between neighbouring states has dramatically reduced the incidence of malaria.
Al Jazeera's report by Mara Kardas-Nelson (DDT's pesky proponents Apr. 21, 2014) rakes over old ground and is replete with misstatements and falsehoods.Read more »
Drug-resistant malaria strains are emerging in mainland Southeast Asia.
French pharmaceutical giant Sanofi announced Tuesday the delivery of the first anti-malaria drugs using a semi-synthetic version of their key ingredient to millions of patients in Africa.
Ebola, malaria and cholera share common symptoms early on, including fever and vomiting, which can cause confusion among patients
A new genome-editing technique can disrupt a single malaria parasite gene with a success rate of up to 100 percent in a matter of weeks, says a study.
If you have ever traveled to a densely tropical area, you have probably taken anti-malaria medications.Read more »
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children
Mozambique adopted artemisinin-based combination therapy (ACT) for the treatment of uncomplicated Plasmodium falciparum malaria in the year 2006, and since 2009 artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) have been proposed as alternative first-line treatments.
While significant advances have been made in the prevention and treatment of malaria in recent years, these successes continue to fall short of the World Health Organization (WHO) goals for malaria control and elimination.
Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya
Artemisinin-based combination therapy (ACT) has been adopted as the most effective treatment against malaria in many endemic countries...
Albeit pregnancy-associated malaria (PAM) poses a potential risk for over 125 million women each year, an accurate review assessing the impact on malaria in infants has yet to be conducted.
"We have become doctors for ourselves": motives for malaria self-care among adults in southeastern Tanzania
Prompt and appropriate treatment of malaria with effective medicines remains necessary if malaria control goals are to be achieved.Read more »